RNA synthesis, which is also called DNA transcription, is a highly selective process.Beyond RNA synthesis, RNA polymerase II transcription plays a more active role in the maturation, monitoring, and export of mRNA to the cytoplasm.
In order to fully repair the DNA after a single-strand break, DNA ligase constructs the final phosphodiester bond using the complementary strand of the double helix as a template.Substrates with RNA strands or mismatched base pairs near the ends of the nicked DNA are discriminated against by DNA ligases. Bleomycin (BLM) is a S-independent radiomimetic agent that damages DNA by creating free radicals that attack the C-4′ position in the deoxyribose backbone. This causes the ribose ring to open and strand breaks to occur.
M-MuLV Reverse Transcriptase (RNase H) and random hexamer primers are used to create first strand cDNA. The next step involves the use of DNA Polymerase I and RNase H to create second strand cDNA. Exonuclease/polymerase activity transforms the remaining overhangs into blunt ends. DNA fragments' 3′ ends are adenylated before being ligated with a NEBNext Adaptor with a hairpin loop structure to get the samples ready for hybridization. The two pathways that BET bromodomain inhibition most commonly affects are cell cycle and DNA replication. The translation of mRNA into proteins is inhibited by cycloheximide.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V12088 | Fexinidazole | 59729-37-2 | Fexinidazole (Hoe239; Hoe-239) is a novel, potent and nitroimidazole-based antiparasitic agent that has been approved in 2021 by FDA as the first all-oral medication to treat African trypanosomiasis caused by Trypanosoma brucei gambiense. | |
V1465 | Fidaxomicin (OPT-80) | 873857-62-6 | Fidaxomicin (formerlyOPT-80, PAR-101; PAR101; OPT80; Dificid; Dificlir; Clostomicin B1; Difimicin; Lipiarmycin; Tiacumicin B) is a narrow spectrum macrocyclic antibiotic agent and a naturally occuringfermentation product extracted from the actinomycete Dactylosporangium aurantiacum subspecies hamdenesisthat. | |
V21027 | Filibuvir | 877130-28-4 | Filibuvir (PF00868554;PF-00868554) is a novel and potent NS5B inhibitor of thenon-nucleoside inhibitor (NNI) class developed for the treatment of hepatitis C. | |
V1448 | Floxuridine | 50-91-9 | Floxuridine (5-fluorodeoxyuridine; Deoxyfluorouridine, FDUR, NSC-27640; FdUrD; fluorodeoxyuridine; fluorouridine deoxyribose; FUDF; 5FUDR; FUdR; WR138720) is an antimetabolite anticancer drug approved for the treatment of colon carcinoma and colorectal cancer that has metastasized to the liver. | |
V1379 | Fludarabine (NSC 118218) | 21679-14-1 | Fludarabine (also known as FaraA; Fludarabinum; NSC-118218; F-ara-A; HSDB6964; NSC118218; HSDB-6964)is a potent STAT1 activation inhibitor and a DNA synthesis inhibitor that has been approved as a chemotherapeutic drug for the treatment of leukemia and lymphoma. | |
V1472 | Fludarabine Phosphate (NSC 118218) | 75607-67-9 | Fludarabine phosphate (formerly F-ara-A; Fludara; Beneflur; 2FaraAMP; NSC312887; NSC-312887),the phosphate salt of Fludarabine, is an adenosine analog and potent STAT-1 activation inhibitor with potential antineoplastic activity. | |
V1447 | Flunarizine 2HCl | 22348-32-9 | Flunarizine 2HCl (formerly R-14950;KW3149; R14950;KW 3149; trade name Sibelium), the dihydrochloride salt form of Flunarizine,is a selective calcium entry/channel blocker with calmodulin binding properties and anti-histamine H1 activity. | |
V1462 | Fluorouracil (5-Fluoracil, 5-FU) | 51-21-8 | Fluorouracil (formerly 5-FU; NSC-19893; NSC19893; 5-Fluorouracil), an analogue of uracil, is an approved anticancer medication acting asa potent DNA/RNA synthesis inhibitor. | |
V1475 | Flupirtine maleate (D 9998) | 75507-68-5 | Flupirtine maleate(W2964; W-2964M; D9998;W-2964; D-9998; Katadolon), the maleate salt form of Flupirtine, is a centrally acting non-opioid analgesic agent and a selective neuronal potassium channel opener that also has NMDA receptor antagonist properties. | |
V5234 | Folic acid (Vitamin B9; Vitamin M) | 59-30-3 | Folic acid (also known as Vitamin M; Vitamin B9; folate) is a one of the B vitamins and is necessary for the production and maintenance of new cells, for DNA synthesis and RNA synthesis. | |
V34803 | Foscarnet trisodium hexahydrate (Trisodium phosphonoformate hexahydrate; Phosphonoformic acid trisodium salt hexahydrate) | 34156-56-4 | Foscarnet trisodium hexahydrate is an inhibitor of viral DNA polymerase activity and reversibly inhibits viral replication. | |
V85130 | G-quadruplex ligand 1 | 1023617-96-0 | ||
V32692 | GC7 Sulfate | 150417-90-6 | GC7 Sulfate, the sulfate salt of GC-7 (N1-guanyl-1,7-diaminoheptane), is a novel and potent deoxyhypusine synthase (DHPS) inhibitor that inhibits Neuroblastoma (NB) cell proliferation in a dose-dependent manner, through induction of the cell cycle inhibitor p21 and reduction of total and phosphorylated Rb proteins. | |
V1478 | Gemcitabine | 95058-81-4 | Gemcitabine (formerly LY-188011, NSC-613327; LY188011, NSC613327; dFdC; dFdCyd; trade name: Gemzar), an approved antimetabolite anticancer drug, is a potent DNA synthesis inhibitor with potential antineoplastic activity. | |
V1423 | Gemcitabine HCl | 122111-03-9 | GemcitabineHCl (formerly also known as LY-188011, NSC-613327; dFdC; dFdCyd; trade name: Gemzar), the hydrochloride salt of gemcitabine which is anantimetabolite anticancer drug,is a potent DNA synthesis inhibitor approved for cancer treatment. | |
V4299 | GS-441524 | 1191237-69-0 | GS-441524 is an active metabolite of Remdesivir (GS-5734; Veklury) which is an FDA approved antiviral drug for treating 2019-nCoV (COVID-19 pandemic, CoronaVirus) infections. | |
V55120 | H3B-968 | 2912294-90-5 | H3B-968 is a novel inhibitor of Werner syndrome protein (WRN), an ATPase, exonuclease, and helicase (IC50=~10 nM). | |
V52005 | HBV-IN-4 | 2305897-84-9 | HBV-IN-4, a phthalazinone derivative, is a novel and selective HBV DNA replication inhibitor with an IC50 of 14 nM. | |
V79496 | hDHODH-IN-12 | hDHODH-IN-12 is a potent DHODH inhibitor (antagonist) with IC50 of 0.421 μM. | ||
V51993 | Heliquinomycin | 178182-49-5 | Heliquinomycin is a DNA helicase (Ki: 6.8 μM) inhibitor and can inhibit the synthesis of DNA and RNA. Heliquinomycin possesses potent antibacterial action against strains of Gram-positive bacteria. |